Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia”
Abstract Aims The Guidelines for the Pharmacotherapy of Schizophrenia were established to improve the quality of medical care, and the EGUIDE project was conducted to train clinicians on guideline usage. A quality indicator (QI) was established to measure the prevalence of the guidelines, and a surv...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-12-01
|
| Series: | Neuropsychopharmacology Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/npr2.12293 |
| _version_ | 1797979242937450496 |
|---|---|
| author | Ken Inada Kentaro Fukumoto Naomi Hasegawa Yuka Yasuda Hisashi Yamada Hikaru Hori Kayo Ichihashi Hitoshi Iida Kazutaka Ohi Hiroyuki Muraoka Fumitoshi Kodaka Kenta Ide Naoki Hashimoto Jun‐ichi Iga Kazuyoshi Ogasawara Kiyokazu Atake Yoshikazu Takaesu Tatsuya Nagasawa Hiroshi Komatsu Tsuyoshi Okada Ryuji Furihata Mikio Kido Saya Kikuchi Chika Kubota Manabu Makinodan Shinichiro Ochi Masahiro Takeshima Hirotaka Yamagata Junya Matsumoto Kenichiro Miura Masahide Usami Taishiro Kishimoto Toshiaki Onitsuka Eiichi Katsumoto Akitoyo Hishimoto Shusuke Numata Norio Yasui‐Furukori Koichiro Watanabe Ryota Hashimoto |
| author_facet | Ken Inada Kentaro Fukumoto Naomi Hasegawa Yuka Yasuda Hisashi Yamada Hikaru Hori Kayo Ichihashi Hitoshi Iida Kazutaka Ohi Hiroyuki Muraoka Fumitoshi Kodaka Kenta Ide Naoki Hashimoto Jun‐ichi Iga Kazuyoshi Ogasawara Kiyokazu Atake Yoshikazu Takaesu Tatsuya Nagasawa Hiroshi Komatsu Tsuyoshi Okada Ryuji Furihata Mikio Kido Saya Kikuchi Chika Kubota Manabu Makinodan Shinichiro Ochi Masahiro Takeshima Hirotaka Yamagata Junya Matsumoto Kenichiro Miura Masahide Usami Taishiro Kishimoto Toshiaki Onitsuka Eiichi Katsumoto Akitoyo Hishimoto Shusuke Numata Norio Yasui‐Furukori Koichiro Watanabe Ryota Hashimoto |
| author_sort | Ken Inada |
| collection | DOAJ |
| description | Abstract Aims The Guidelines for the Pharmacotherapy of Schizophrenia were established to improve the quality of medical care, and the EGUIDE project was conducted to train clinicians on guideline usage. A quality indicator (QI) was established to measure the prevalence of the guidelines, and a survey was conducted, which revealed a gap between the guidelines and actual clinical practice (evidence‐practice‐gap). The purpose of this study was to develop an individual fitness score (IFS) formula that expresses the degree to which prescribers adhere to the Guidelines for Pharmacological Therapy of Schizophrenia in a simple manner, and to determine the validity of this formula from a survey of the prescriptions of the EGUIDE project participants'. Methods To establish appropriate scores, members discussed the proposed formula and then voted on them. The IFS formula developed was set up so that antipsychotic monotherapy would be given 100 points, with points deducted if concomitant or adjunctive antipsychotic medications were used, and a minimum score of 0. To validate this formula, prescriptions of hospitalized schizophrenic patients at admission and at discharge were scored and compared. Result IFS points vary and ranged from 0 to100. The average pre‐admission score for all subjects was 45.6, and the average score at discharge was 54, those were significantly higher during discharge. Conclusions We developed an IFS formula, a tool to easily visualize the degree to which current prescriptions conform to the guidelines for the pharmacological treatment of schizophrenia. |
| first_indexed | 2024-04-11T05:35:52Z |
| format | Article |
| id | doaj.art-71db657687454769b1c8f814ad0c4bbd |
| institution | Directory Open Access Journal |
| issn | 2574-173X |
| language | English |
| last_indexed | 2024-04-11T05:35:52Z |
| publishDate | 2022-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Neuropsychopharmacology Reports |
| spelling | doaj.art-71db657687454769b1c8f814ad0c4bbd2022-12-22T12:22:50ZengWileyNeuropsychopharmacology Reports2574-173X2022-12-0142450250910.1002/npr2.12293Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia”Ken Inada0Kentaro Fukumoto1Naomi Hasegawa2Yuka Yasuda3Hisashi Yamada4Hikaru Hori5Kayo Ichihashi6Hitoshi Iida7Kazutaka Ohi8Hiroyuki Muraoka9Fumitoshi Kodaka10Kenta Ide11Naoki Hashimoto12Jun‐ichi Iga13Kazuyoshi Ogasawara14Kiyokazu Atake15Yoshikazu Takaesu16Tatsuya Nagasawa17Hiroshi Komatsu18Tsuyoshi Okada19Ryuji Furihata20Mikio Kido21Saya Kikuchi22Chika Kubota23Manabu Makinodan24Shinichiro Ochi25Masahiro Takeshima26Hirotaka Yamagata27Junya Matsumoto28Kenichiro Miura29Masahide Usami30Taishiro Kishimoto31Toshiaki Onitsuka32Eiichi Katsumoto33Akitoyo Hishimoto34Shusuke Numata35Norio Yasui‐Furukori36Koichiro Watanabe37Ryota Hashimoto38Department of Psychiatry, School of Medicine Kitasato University Sagamihara JapanDepartment of Neuropsychiatry Iwate Medical University Iwate JapanDepartment of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Tokyo JapanDepartment of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Tokyo JapanDepartment of Neuropsychiatry Hyogo Medical College Hyogo JapanDepartment of Psychiatry Faculty of Medicine Fukuoka University Fukuoka JapanDepartment of Neuropsychiatry University of Tokyo Hospital Tokyo JapanDepartment of Psychiatry Faculty of Medicine Fukuoka University Fukuoka JapanDepartment of Psychiatry Gifu University Graduate School of Medicine Gifu JapanDepartment of Psychiatry Tokyo Women's Medical University Tokyo JapanDepartment of Psychiatry The Jikei University School of Medicine Tokyo JapanDepartment of Hospital Pharmacy Hospital of University of Occupational and Environmental Health Fukuoka JapanDepartment of Psychiatry Hokkaido University Graduate School of Medicine Hokkaido JapanDepartment of Neuropsychiatry Ehime University Graduate School of Medicine Ehime JapanCenter for Postgraduate Clinical Training and Career Development Nagoya University Hospital Achi JapanNippon Telegraph and Telephone West Corporation Kyushu Health Administration Center Fukuoka JapanDepartment of Neuropsychiatry, Graduate School of Medicine University of the Ryukyus Okinawa JapanDepartment of NeuroPsychiatry Kanazawa Medical University Ishikawa JapanDepartment of Psychiatry Tohoku University Hospital Miyagi JapanDepartment of Psychiatry Jichi Medical University Tochigi JapanAgency for Student Support and Disability Resources Kyoto University Kyoto JapanKido Clinic Toyama JapanDepartment of Psychiatry Tohoku University Hospital Miyagi JapanDepartment of Psychiatry, National Center Hospital National Center of Neurology and Psychiatry Tokyo JapanDepartment of Psychiatry Nara Medical University Nara JapanDepartment of Neuropsychiatry, Molecules and Function Ehime University Graduate School of Medicine Ehime JapanDepartment of Neuropsychiatry Akita University Graduate School of Medicine Akita JapanDivision of Neuropsychiatry Department of Neuroscience Yamaguchi University School of Medicine Yamaguchi JapanDepartment of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Tokyo JapanDepartment of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Tokyo JapanDepartment of Child and Adolescent Psychiatry, Kohnodai Hospital National Center for Global Health and Medicine Chiba JapanHills Joint Research Laboratory for Future Preventive Medicine and Wellness Keio University School of Medicine Tokyo JapanDepartment of Neuroimaging Psychiatry, Graduate School of Medical Sciences Kyushu University Fukuoka JapanKatsumoto Mental Clinic Osaka JapanDepartment of Psychiatry Yokohama City University Graduate School of Medicine Kanagawa JapanDepartment of Psychiatry, Graduate School of Biomedical Science Tokushima University Tokushima JapanDepartment of Psychiatry Dokkyo Medical University School of Medicine Tochigi JapanDepartment of Neuropsychiatry, School of Medicine Kyorin University Tokyo JapanDepartment of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Tokyo JapanAbstract Aims The Guidelines for the Pharmacotherapy of Schizophrenia were established to improve the quality of medical care, and the EGUIDE project was conducted to train clinicians on guideline usage. A quality indicator (QI) was established to measure the prevalence of the guidelines, and a survey was conducted, which revealed a gap between the guidelines and actual clinical practice (evidence‐practice‐gap). The purpose of this study was to develop an individual fitness score (IFS) formula that expresses the degree to which prescribers adhere to the Guidelines for Pharmacological Therapy of Schizophrenia in a simple manner, and to determine the validity of this formula from a survey of the prescriptions of the EGUIDE project participants'. Methods To establish appropriate scores, members discussed the proposed formula and then voted on them. The IFS formula developed was set up so that antipsychotic monotherapy would be given 100 points, with points deducted if concomitant or adjunctive antipsychotic medications were used, and a minimum score of 0. To validate this formula, prescriptions of hospitalized schizophrenic patients at admission and at discharge were scored and compared. Result IFS points vary and ranged from 0 to100. The average pre‐admission score for all subjects was 45.6, and the average score at discharge was 54, those were significantly higher during discharge. Conclusions We developed an IFS formula, a tool to easily visualize the degree to which current prescriptions conform to the guidelines for the pharmacological treatment of schizophrenia.https://doi.org/10.1002/npr2.12293clinical practice guidelineindividual fitness score (IFS)prescriptionquality indicatorschizophrenia |
| spellingShingle | Ken Inada Kentaro Fukumoto Naomi Hasegawa Yuka Yasuda Hisashi Yamada Hikaru Hori Kayo Ichihashi Hitoshi Iida Kazutaka Ohi Hiroyuki Muraoka Fumitoshi Kodaka Kenta Ide Naoki Hashimoto Jun‐ichi Iga Kazuyoshi Ogasawara Kiyokazu Atake Yoshikazu Takaesu Tatsuya Nagasawa Hiroshi Komatsu Tsuyoshi Okada Ryuji Furihata Mikio Kido Saya Kikuchi Chika Kubota Manabu Makinodan Shinichiro Ochi Masahiro Takeshima Hirotaka Yamagata Junya Matsumoto Kenichiro Miura Masahide Usami Taishiro Kishimoto Toshiaki Onitsuka Eiichi Katsumoto Akitoyo Hishimoto Shusuke Numata Norio Yasui‐Furukori Koichiro Watanabe Ryota Hashimoto Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia” Neuropsychopharmacology Reports clinical practice guideline individual fitness score (IFS) prescription quality indicator schizophrenia |
| title | Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia” |
| title_full | Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia” |
| title_fullStr | Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia” |
| title_full_unstemmed | Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia” |
| title_short | Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia” |
| title_sort | development of individual fitness score for conformity of prescriptions to the guidelines for pharmacological therapy of schizophrenia |
| topic | clinical practice guideline individual fitness score (IFS) prescription quality indicator schizophrenia |
| url | https://doi.org/10.1002/npr2.12293 |
| work_keys_str_mv | AT keninada developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT kentarofukumoto developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT naomihasegawa developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT yukayasuda developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT hisashiyamada developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT hikaruhori developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT kayoichihashi developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT hitoshiiida developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT kazutakaohi developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT hiroyukimuraoka developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT fumitoshikodaka developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT kentaide developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT naokihashimoto developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT junichiiga developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT kazuyoshiogasawara developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT kiyokazuatake developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT yoshikazutakaesu developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT tatsuyanagasawa developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT hiroshikomatsu developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT tsuyoshiokada developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT ryujifurihata developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT mikiokido developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT sayakikuchi developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT chikakubota developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT manabumakinodan developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT shinichiroochi developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT masahirotakeshima developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT hirotakayamagata developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT junyamatsumoto developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT kenichiromiura developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT masahideusami developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT taishirokishimoto developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT toshiakionitsuka developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT eiichikatsumoto developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT akitoyohishimoto developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT shusukenumata developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT norioyasuifurukori developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT koichirowatanabe developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia AT ryotahashimoto developmentofindividualfitnessscoreforconformityofprescriptionstotheguidelinesforpharmacologicaltherapyofschizophrenia |